Top Health Care Stocks
Health care stocks were narrowly lower in recent trade, with the NYSE Health Care Index declining less than 0.1% while shares of health care companies in the S&P 500 were down nearly 0.2% as a group.
In company news, Novocure Ltd ( NVCR ) rallied Monday after the specialty drugmaker today reported positive results from Phase III testing of a combination of its Optune product candidate plus temozolomide in 695 patients with a form of brain cancer.
The survival rate for glioblastoma patients treated with the drug combination increased from 30% to 43% after two years and rose from 5% to 13% of the patients after five years, which were the best results reported so far for newly diagnosed glioblastoma patients during late-stage testing.
NVCR shares were up more than 44% at $11.70 apiece, earlier topping out at $14.30 a share.
In other sector news,
(+) CYCC, (+58.9%) Presents positive data for CYC065 drug candidate, saying the second-generation, cyclin-dependent kinase 2/9 inhibitor substantially inhibited growth and triggered apoptosis in murine and human lung cancer cells.
(-) EKSO, (-17.8%) Prices $11.6 mln private placement of 3.7 mln shares of common stock at a price of $3.14 apiece. Deal also includes warrants to buy up to nearly 1.9 mln additional shares at $4.10 each.
Copyright (C) 2016 MTNewswires.com. All rights reserved. Unauthorized reproduction is strictly prohibited.